Research / ITP / Fundamental state Inspectable configuration
State dimensions Filing 0001213900-21-058146 General Corporate
Debt relative to revenue 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
21.41% · OPTIONAL · VALID
Capex intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
27.97% · OPTIONAL · VALID
Operating cash generation 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
20.24% · OPTIONAL · VALID
Revenue growth 72th Own-history percentile · N=18
Evidence method Yoy · gp.fundamentals.revenue
35.17% · CORE · VALID
Inventory pressure 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
16.90% · OPTIONAL · VALID
Gross margin 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
4.04% · CORE · VALID
Operating margin 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-0.44% · CORE · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 40 states Self-history eligible
Dec 31, 2020 7/9 normalized Amended as filed Mar 31, 2021 7/7 normalized Level 3 Jun 30, 2021 7/7 normalized Level 3 Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/9 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 6/7 normalized Level 3 Mar 31, 2024 6/6 normalized Level 3 Jun 30, 2024 6/6 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 20.82%
Current 21.41%
Delta 0.58% Capex Intensity Increased
Previous 0.27%
Current 27.97%
Delta 27.69% Cash Generation Increased
Previous -15.67%
Current 20.24%
Delta 35.91% Growth Decreased
Previous 76.52%
Current 35.17%
Delta -41.36% Inventory Pressure Decreased
Previous 25.08%
Current 16.90%
Delta -8.18% Margin Decreased
Previous 6.51%
Current 4.04%
Delta -2.47% Profitability Decreased
Previous 0.93%
Current -0.44%
Delta -1.37% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.